chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Anion gap, Blood culture negative, Blood glucose fluctuation, Blood ketone body increased, COVID-19
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Carbon dioxide decreased, Chest X-ray normal, Communication disorder, Condition aggravated, Confusional state
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine positive, Death, Decreased appetite, Dementia, Diabetic ketoacidosis
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Diet refusal, Encephalopathy, Escherichia test positive, General physical health deterioration, Hyperglycaemia
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Intensive care, Laboratory test, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis normal
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21, and 12/13/21. Presented to ER on 7/26/22. Found to be COVID positive 8/5/22. She was initially admitted to HospitalF on 7/26 with confusion, UTI, and hyperglycemia. This was associated with decreased appetite and reported functional decline with worsening dementia over the past few months. Urine culture was positive for pan-susceptible E. Coli. She completed a course of Ceftriaxone. Throughout her admission, blood glucose was labile; significantly elevated, punctuated by periods of lows. Patient was pending discharge to facility but pre-placement COVID screening resulted as positive on 8/5, delaying transfer. In the morning of 8/7, her blood glucose was noted to be significantly elevated and chemistry panel was obtained. This demonstrated anion gap of 31, CO2 of 7 and blood glucose of 633. She had a large amount of acetone in her serum. She was noted to be encephalopathic. Findings consistent with DKA. She was transferred to from 5100 to ICU with intensivist consultation.    Kept NPO, started broad-spectrum antibiotics for possible sepsis, sepsis protocol initiated, chest x-ray showed no infiltrate on 08/07, UA did not show evidence of infection on 08/07, blood cultures and urine culture are negative so far.   Patient is out of DKA on 08/08/2022, bridged with long-acting, but patient is not eating even though awake, also remained noncommunicative later on, patient has severe dementia history and poor functional status, daughter and son continued to wish against tube feeding, goal of care discussion initiated with family and family members opted for hospice care.  Patient will be discharged to facility with the hospice care. Discharged on 8/10/22. Passed away on 8/12/22
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Starting Friday, Aug 12th, I had breakthrough menstrual bleeding. It's a moderate flow and is still continuing. Today is day 5. I have not had any heavy bleeding for about 3-4 months. I had a uterine ablation in October of 2021.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 1.08
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site mass
Clinical narrative: MOTHER REPORTS A LUMP AT THE INJECTION SITE
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest discomfort, Chest pain, Electrocardiogram, Exercise tolerance decreased
Clinical narrative: Starting March 24 I began to get heart palpitations, irregular heartbeats, muscle spasms, constant chest pain (pressure feeling), brain fog, fatigue, I haven?t been able to workout or live life normally like I used to. It?s been almost 5 months and the side affects are still there.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Heart rate irregular, Muscle spasms, Palpitations
Clinical narrative: Starting March 24 I began to get heart palpitations, irregular heartbeats, muscle spasms, constant chest pain (pressure feeling), brain fog, fatigue, I haven?t been able to workout or live life normally like I used to. It?s been almost 5 months and the side affects are still there.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Fall
Clinical narrative: 3 minutes after patient received the vaccine, patient experienced lightheadedness and dizziness and fell forward from a standing position. Pharmacist caught the patient, and laid him onto the ground. Patient was responsive and was then moved to sit on a chair. Patient received water, felt better, and was able to leave the pharmacy with his dad after 10 minutes.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Coagulopathy, Lethargy, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 3/18/21, 4/15/21, and 1/6/22. Presented to ER on 7/13/22. COVID positive on 8/6/22. Admitted on 7/13 for lethargy and patient lying on floor. The patient was ready to be discharged but then he had  a positive COVID test without any COVID symptoms.  He was kept in hospital  for 3 more days and observed.  He has not developed any fever, chills,  diaphoresis.  Discharged on 8/8/22
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: 4yo; got orange vaccine first shot  (6/23/22) and maroon second shot (7/19/22)  called family with this guidance: Children ages 6 months?4 years who receive different mRNA products for the first 2 doses of an mRNA COVID-19 vaccine series should follow a 3-dose schedule. A third dose of either mRNA vaccine should be administered 8 weeks after the second dose to complete the 3-dose primary series. Family states they will call scheduling for third dose.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Anticoagulant therapy, Breast feeding, COVID-19, Caesarean section
Clinical narrative: Patient received Pfizer vaccine on 5/26/21, 6/16/21 and 12/13/21. Presented to ER on 8/5/22 to give birth at 39 weeks gestation. Found to be COVID positive. Patient was admitted for repeat cesarean section. Please see operative note for full details. On POD#1 she was advance and reports pain is well controlled with oral medications and denies heavy bleeding. She was ambulating, tolerating regular diet, and voiding without difficulty. She was noted to have anemia and was started on iron supplementation. She was having a fever with temp 101 F, nasal congestion and headache and was noted to be COVID +. On POD#2 she was meeting all of her postoperative and postpartum milestones and was passing flatus. She was feeling better and was afebrile for > 24 hours. She is breast & bottle feeding without difficulty. Fundus is firm and below umbilicus, no LE edema. She is felt stable for discharge home. She was given standard postoperative precautions and restrictions. She was given COVID 19 precautions and restrictions. She was discharged home on Lovenox 40 mg QD and was given DVT/PE precautions on 8/7/22.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Headache, Nasal congestion, Pain, Pyrexia
Clinical narrative: Patient received Pfizer vaccine on 5/26/21, 6/16/21 and 12/13/21. Presented to ER on 8/5/22 to give birth at 39 weeks gestation. Found to be COVID positive. Patient was admitted for repeat cesarean section. Please see operative note for full details. On POD#1 she was advance and reports pain is well controlled with oral medications and denies heavy bleeding. She was ambulating, tolerating regular diet, and voiding without difficulty. She was noted to have anemia and was started on iron supplementation. She was having a fever with temp 101 F, nasal congestion and headache and was noted to be COVID +. On POD#2 she was meeting all of her postoperative and postpartum milestones and was passing flatus. She was feeling better and was afebrile for > 24 hours. She is breast & bottle feeding without difficulty. Fundus is firm and below umbilicus, no LE edema. She is felt stable for discharge home. She was given standard postoperative precautions and restrictions. She was given COVID 19 precautions and restrictions. She was discharged home on Lovenox 40 mg QD and was given DVT/PE precautions on 8/7/22.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer vaccine on 5/26/21, 6/16/21 and 12/13/21. Presented to ER on 8/5/22 to give birth at 39 weeks gestation. Found to be COVID positive. Patient was admitted for repeat cesarean section. Please see operative note for full details. On POD#1 she was advance and reports pain is well controlled with oral medications and denies heavy bleeding. She was ambulating, tolerating regular diet, and voiding without difficulty. She was noted to have anemia and was started on iron supplementation. She was having a fever with temp 101 F, nasal congestion and headache and was noted to be COVID +. On POD#2 she was meeting all of her postoperative and postpartum milestones and was passing flatus. She was feeling better and was afebrile for > 24 hours. She is breast & bottle feeding without difficulty. Fundus is firm and below umbilicus, no LE edema. She is felt stable for discharge home. She was given standard postoperative precautions and restrictions. She was given COVID 19 precautions and restrictions. She was discharged home on Lovenox 40 mg QD and was given DVT/PE precautions on 8/7/22.
Age: 18.0
Sex: F
Vaccine: HEP, MENB
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Client came to clinic for Men B #1.  Sibling also came to clinic for Men B #1, Hep B #3, and MCV4 #2.  Client was accidentally given Hep B dose that sibling was supposed to get.  Informed client of error.  Client reported no problems after receiving Hep B.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Cardiac disorder, Cardiac monitoring, Cardiac stress test, Echocardiogram abnormal
Clinical narrative: I was on travel and in a hotel Friday early morning I passed out in my hotel room and woke up with right sided numbness. Transported to ED at Medical Center and evaluated for stroke, pulmonary embolism and both were negative. Troponin levels showed I had heart damage and was given an ECHO/EKG and diagnosed with a Non-ST-Elevation Myocardial Infarction (NSTEMI). ECHO was inconclusive but shows left ventricle is mildly dilated with ejection fraction around 45% (taking into account limitations due to non-contrast and limited visualization. I am currently undergoing follow-up tests including a heart monitor for two weeks (ends 8/22), a stress test and ECHO cardio with contrast (9/8/22), and referred to a neurologist (9/26/22)
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram abnormal, Hypoaesthesia, Laboratory test normal, Left ventricular dilatation
Clinical narrative: I was on travel and in a hotel Friday early morning I passed out in my hotel room and woke up with right sided numbness. Transported to ED at Medical Center and evaluated for stroke, pulmonary embolism and both were negative. Troponin levels showed I had heart damage and was given an ECHO/EKG and diagnosed with a Non-ST-Elevation Myocardial Infarction (NSTEMI). ECHO was inconclusive but shows left ventricle is mildly dilated with ejection fraction around 45% (taking into account limitations due to non-contrast and limited visualization. I am currently undergoing follow-up tests including a heart monitor for two weeks (ends 8/22), a stress test and ECHO cardio with contrast (9/8/22), and referred to a neurologist (9/26/22)
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Scan with contrast, Troponin abnormal
Clinical narrative: I was on travel and in a hotel Friday early morning I passed out in my hotel room and woke up with right sided numbness. Transported to ED at Medical Center and evaluated for stroke, pulmonary embolism and both were negative. Troponin levels showed I had heart damage and was given an ECHO/EKG and diagnosed with a Non-ST-Elevation Myocardial Infarction (NSTEMI). ECHO was inconclusive but shows left ventricle is mildly dilated with ejection fraction around 45% (taking into account limitations due to non-contrast and limited visualization. I am currently undergoing follow-up tests including a heart monitor for two weeks (ends 8/22), a stress test and ECHO cardio with contrast (9/8/22), and referred to a neurologist (9/26/22)
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Case vaccinated with moderna x 2 in 2021. Tested positive for Covid 19 on 08/02/2022. Admitted to  Medical Center on 8/14/2022 and expired on 08/15/2022 while still hospitalized.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 4yo; got orange vaccine first shot (7/1/22) and maroon second shot (7/22/22)  called family with this guidance: Children ages 6 months?4 years who receive different mRNA products for the first 2 doses of an mRNA COVID-19 vaccine series should follow a 3-dose schedule. A third dose of either mRNA vaccine should be administered 8 weeks after the second dose to complete the 3-dose primary series. Family states they will call scheduling for third dose.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Urticaria
Clinical narrative: Patient had hives, Injection site was tendered and red. Little bit inflamed
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with one booster.   COVID breakthrough infection
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Moderna (6m-4yr) vial was pulled from the Refrigerator 8/15/22 at 0745, Lot # AS1414B.  At around 1200 it was noticed that the vaccine BUD date was 8/12/22 and it should have been discarded on 8/12/22.  There were two doses given from this vial, patient being one of the patients. The incident was reported to Moderna and I was told we would be getting notification in 3 days in regards to the stability of the vaccine given and the next steps to take.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: None stated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: No reaction to vaccine.  However, I came down with Covid symptoms on 8/5/2022 and was diagnosed with it (PCR Test) on 8/7/2022
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted once.   COVID breakthrough infection
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Can't smell or taste since a month after having vaccine.  I had to get vaccine since I'm in healthcare field.  Never had Covid prior or during my vaccine.   Did not go back for any other vaccines.  Left the healthcare field.
Age: 15.0
Sex: F
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: Opened IPOL given to patient on 6/22/22 following a temperature excursion. Per DOH, patient needs to be revaccinated. Talked to mom over mom recommending revaccination.
Age: 25.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site bruising
Clinical narrative: Formation of large bruising near injection site (continues to grow) similar to instances of improper blood draws
Age: 0.5
Sex: F
Vaccine: COVID19, DTAPIPVHIB, PNC13, RV5, COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Moderna (6m-4yr) vial was pulled from the Refrigerator 8/15/22 at 0745, Lot # AS1414B. At around 1200 it was noticed that the vaccine BUD date was 8/12/22 and it should have been discarded on 8/12/22. There were two doses given from this vial, Vaccination patient being one of the patients. The incident was reported to Moderna and I was told we would be getting notification in 3 days in regards to the stability of the vaccine given and the next steps to take.
Age: 0.5
Sex: F
Vaccine: COVID19, DTAPIPVHIB, PNC13, RV5, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Moderna (6m-4yr) vial was pulled from the Refrigerator 8/15/22 at 0745, Lot # AS1414B. At around 1200 it was noticed that the vaccine BUD date was 8/12/22 and it should have been discarded on 8/12/22. There were two doses given from this vial, Vaccination patient being one of the patients. The incident was reported to Moderna and I was told we would be getting notification in 3 days in regards to the stability of the vaccine given and the next steps to take.
Age: 17.0
Sex: F
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: Opened IPOL given to patient on 6/22/22 following a temperature excursion. Per DOH, patient needs to be revaccinated. Talked to mom over mom recommending revaccination.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with 2 boosters.   COVID breakthrough infection
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted once.   COVID breakthrough infection
Age: 19.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site coldness, Injection site hypoaesthesia
Clinical narrative: Client called today to say she had numbness and felt cold to the area where she received the vaccine , the 2nd night after receiving the shot but massaged the area and it went away. Says it didn't last long but thought the vaccine may have caused that and was asking me if was and whether she should no longer receive any vaccines. I asked if she continued with numbness or cold feeling and she stated no. Explained to the VIS statement, asked if she still had hers and she replied no. I told her I would file a VAERS report, also to seek Medical doctor if she had any further questions.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with one booster.   COVID breakthrough infection
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Laboratory test, SARS-CoV-2 test positive, Ultrasound scan
Clinical narrative: I woke up with serious chills for 23 days straight. The chills were all day long but I was able to sleep. I went to the doctor and took several test. I tested positive for COVID-19 June 30th 2020.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: I woke up with serious chills for 23 days straight. The chills were all day long but I was able to sleep. I went to the doctor and took several test. I tested positive for COVID-19 June 30th 2020.
Age: 20.0
Sex: F
Vaccine: TDAP
Symptoms: Feeling hot, Flushing
Clinical narrative: patient felt hot and flushed
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Extra dose administered, Fatigue, Feeling abnormal
Clinical narrative: See prior statement that I had COVID, NOT an adverse affect to the vaccine!
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired work ability, Influenza, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: See prior statement that I had COVID, NOT an adverse affect to the vaccine!
Age: 5.0
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event reported. Just a vaccine administration error. 2 brothers were in the same visit and both were due for vaccines. The MA accidentally administered the wrong vaccines to the wrong brother. They then caught their mistake before administering vaccines to the other brother. The brothers were in clinic with their grandmother who was promptly informed of the mistake. The patient remained stable and free of adverse reactions for the remainder of the visit. They were instructed to contact clinic should any adverse reactions occur. We have not heard anything to date.
Age: 45.0
Sex: F
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: Client, age 45, presented to clinic on 8/16/22 for second dose of Hepatitis A 19+ vaccine and HPV. Client received a pediatric dose Hepatitis A 1-18. The recommendation is to repeat the dose with the correct product of Hepatitis A 19+. VAERS will be submitted. This nurse will be contacting the client to inform them that another dose is recommended to ensure adequate protection against Hepatitis A.
Age: 36.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Product administered at inappropriate site
Clinical narrative: Nurse gave the Menveo ID instead of IM. Client had a 20mm light red local reaction around the site of the bleb. No induration, no other adverse reactions.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoaesthesia, Magnetic resonance imaging, Nerve stimulation test, Pain
Clinical narrative: Numbness of arms, legs, fingers and toes. Fatigue sharp stinging pains.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Hypoaesthesia, Impaired work ability, Mobility decreased
Clinical narrative: Numbness of arms, legs, fingers and toes. Fatigue sharp stinging pains.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Paraesthesia, Somnolence
Clinical narrative: Numbness of arms, legs, fingers and toes. Fatigue sharp stinging pains.
Age: 41.0
Sex: M
Vaccine: UNK
Symptoms: Allergy test, Pruritus, Rash, Urticaria, X-ray
Clinical narrative: Ongoing Hives, itchy/rashy skin.  Administered hydroxyzine, loratadine, Allegra, cetirizine, famotidine and a steroid.  None effective at relieving symptoms.
Age: 8.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Medical Provider ordered Hepatitis B vaccine, Nurse administered Meningococcal B vaccine.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune disorder, Blood glucose abnormal, Glycosylated haemoglobin, Laboratory test, Type 1 diabetes mellitus
Clinical narrative: developed autoimmune LOTO Type one diabetes, Metformin and Insulin, sugars controlled A1C improving
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Cough, Fatigue, Oropharyngeal pain
Clinical narrative: I got sore throat; cough; fever; tiredness; tightness in chest for 2 weeks and I took Paxlovid; Albuterol; Promethazine; Benzonathee and throat lozenges.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I got sore throat; cough; fever; tiredness; tightness in chest for 2 weeks and I took Paxlovid; Albuterol; Promethazine; Benzonathee and throat lozenges.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Eye swelling, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Rapid heartbeat, Red and painful swelling at shot site, Stiff neck, Swelling under left eye. Shot in left arm.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal stiffness
Clinical narrative: Rapid heartbeat, Red and painful swelling at shot site, Stiff neck, Swelling under left eye. Shot in left arm.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Magnetic resonance imaging heart, Pericarditis
Clinical narrative: Acute pericarditis.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was expired by less than 72 hours. No adverse event from expired vaccine.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given Covid 19 booster 6 days earlier then they should have - no reactions  Pfizer Lot: FL8095 on the Left Deltoid
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given when it was less than 72 hours expired. No adverse event.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Immunisation reaction, Tendonitis, X-ray
Clinical narrative: A douple days after the vaccine I got COVID arm, it cleared up in about a week. On 4/1/2022 (a month and a half later) I started having really bad shoulder pain in the same vaccinated arm. I went to Urgent Care. I given an X-ray, but nothing was found on the X-ray. The Dr concluded that I had Tendonitis of the shoulder. Was told to take Ibuprophen for the pain and was prescribed  Diclofenac gel to rub on my skin. My condition wasn't getting better, so I saw my PCPs. My Dr showed me exercises to do to help with the healing and pain. When they weren't working I asked to be sent to a PT, hoping that they would be able to advise me better. My Dr. didn't want to give me a a referral so I tried to find some helpful exercises on the internet and they helped a little.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue
Clinical narrative: VanishPoint syringe malfunctioned while in patient's arm and vaccine squirted out of syringe and not into patient's arm. RN notified manager who gave guidance to revaccinate based on CDC recommendations.
Age: 27.0
Sex: F
Vaccine: HPV9
Symptoms: Antinuclear antibody positive, Blood test, C-reactive protein increased, Gait disturbance, Gait inability
Clinical narrative: Patient had severe autoimmune response. Symptoms paralleled rheumatoid arthritis. Patient described pain as uncontrollable and unmanageable. The symptoms began in the hands, with tight and stiff joints, as well as swelling to the extreme that hands could not be closed. These symptoms spread to the shoulders, ankles, and all the joints in the feet. Walking was unbearable, which did not lessen with any OTC pain medications or topical treatments. The patient's toes began to show the same symptoms as the hands, extreme swelling which prohibited walking. These pains lasted longer than 8 weeks.
Age: 27.0
Sex: F
Vaccine: HPV9
Symptoms: Joint stiffness, Pain, Peripheral swelling, Rheumatoid factor negative, X-ray normal
Clinical narrative: Patient had severe autoimmune response. Symptoms paralleled rheumatoid arthritis. Patient described pain as uncontrollable and unmanageable. The symptoms began in the hands, with tight and stiff joints, as well as swelling to the extreme that hands could not be closed. These symptoms spread to the shoulders, ankles, and all the joints in the feet. Walking was unbearable, which did not lessen with any OTC pain medications or topical treatments. The patient's toes began to show the same symptoms as the hands, extreme swelling which prohibited walking. These pains lasted longer than 8 weeks.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Epidural injection, Intervertebral disc protrusion, Lumbar spinal stenosis, Magnetic resonance imaging spinal abnormal
Clinical narrative: On 2/14/2022, I received my second booster of Moderna for COVID-19. On 6/3/2022, I experienced a sciatica flare-up. I have had chronic sciatica for about 5 years now, but it didn't always flare up. Since 6/3/2022, I have had continuous sciatica pain, and this is the worst it has ever been. I saw my doctor on 6/7/2022, and he ordered an MRI procedure, which was done 7/1/2022. The MRI showed one protruding vertebral disk and two areas of stenosis in the lumbar spine. I received an epidural treatment on 6/21/2022, and it did not help at all.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Sciatica
Clinical narrative: On 2/14/2022, I received my second booster of Moderna for COVID-19. On 6/3/2022, I experienced a sciatica flare-up. I have had chronic sciatica for about 5 years now, but it didn't always flare up. Since 6/3/2022, I have had continuous sciatica pain, and this is the worst it has ever been. I saw my doctor on 6/7/2022, and he ordered an MRI procedure, which was done 7/1/2022. The MRI showed one protruding vertebral disk and two areas of stenosis in the lumbar spine. I received an epidural treatment on 6/21/2022, and it did not help at all.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received second booster dose (0.25 ml) of Moderna COVID-19 but later found not to have immunological disorder that would make him eligible to receive the booster dose. No adverse reaction to the vaccine was reported by the patient. Manufacturer was contacted regarding this occurance but no specific guidance was provided aside from ensuring patient does not receive an additional dose of the vaccine.
Age: 0.92
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse symptoms noted. Vaccines were administered five days earlier than minimum valid date.  Provider in office was notified. Father was also notified while in office and advised vaccines will need to be given again. Father educated to monitor for signs of adverse reactions and advised to report them. Father verbalized understanding.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 39.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Blister, Burning sensation, Influenza like illness, Pain, Pyrexia
Clinical narrative: About a day after I received the vaccine, I experienced flu-like symptoms and a low-grade fever. At the same time, painful, burning blisters appeared on my hands and on my right lower leg.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority  on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.  recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question.  Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Child was being held in lap by mother. Child pulled away when needle entered L thigh. Dose was not administered and wasted. Child was revaccinated with new dose and syringe.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Altered state of consciousness, Dry mouth, Erythema, Eye movement disorder, Head titubation
Clinical narrative: AFTER GIVING THE SHOT, WHILE EXPLAINING THE AFTER CARE TO THE PATIENT AND HER MOM, (WHO WAS PRESENT IN THE CONSULTATION ROOM), WE NOTICED THE PATIENT WAS ABOUT TO PASS OUT. HER HEAD STARTED FALLING TO ONE SIDE, HER EYES ROLLED UP AND HER HEAD WENT BACK. HER FACE AND NECK COLOR TURNED RED . WE HELD AN ICE PACK TO HER NECK AND FOREHEAD , RAISED HER LEGS WITH AN ADDITIONAL CHAIR WHILE SUPPORTING HER HEAD AND BACK (RESTING IN THE CHAIR WHERE THE VACCINE WAS GIVEN). ONE RX TECH CALLED FOR MEDICAL HELP.  THE PATIENT WAS IN AND OUT OF CONSCIOUSNESS, HER MOUTH WAS DRY. SHE NODDED HER HEAD FOR SOME WATER WHICH SHE TOOK SIPS OF IN BETWEEN TAKING DEEP BREATHS, IN THE MEANTIME THE PARAMEDICS ARRIVED AND SPOKE TO HER TO FIGURE OUT HER CONDITION AND HOW IT HAPPENED. SHE WAS THEN TRANSPORTED VIA AN AMBULANCE TO THE ER  OF THE LOCAL HOSPITAL WHERE SHE WAS GIVEN FURTHER CARE.  IN ABOUT AN HOUR AND HALF, WE CHECKED WITH HER MOM WHO CONFIRMED THAT SHE WAS DOING MUCH BETTER AND HER COLOR WAS BACK
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: AFTER GIVING THE SHOT, WHILE EXPLAINING THE AFTER CARE TO THE PATIENT AND HER MOM, (WHO WAS PRESENT IN THE CONSULTATION ROOM), WE NOTICED THE PATIENT WAS ABOUT TO PASS OUT. HER HEAD STARTED FALLING TO ONE SIDE, HER EYES ROLLED UP AND HER HEAD WENT BACK. HER FACE AND NECK COLOR TURNED RED . WE HELD AN ICE PACK TO HER NECK AND FOREHEAD , RAISED HER LEGS WITH AN ADDITIONAL CHAIR WHILE SUPPORTING HER HEAD AND BACK (RESTING IN THE CHAIR WHERE THE VACCINE WAS GIVEN). ONE RX TECH CALLED FOR MEDICAL HELP.  THE PATIENT WAS IN AND OUT OF CONSCIOUSNESS, HER MOUTH WAS DRY. SHE NODDED HER HEAD FOR SOME WATER WHICH SHE TOOK SIPS OF IN BETWEEN TAKING DEEP BREATHS, IN THE MEANTIME THE PARAMEDICS ARRIVED AND SPOKE TO HER TO FIGURE OUT HER CONDITION AND HOW IT HAPPENED. SHE WAS THEN TRANSPORTED VIA AN AMBULANCE TO THE ER  OF THE LOCAL HOSPITAL WHERE SHE WAS GIVEN FURTHER CARE.  IN ABOUT AN HOUR AND HALF, WE CHECKED WITH HER MOM WHO CONFIRMED THAT SHE WAS DOING MUCH BETTER AND HER COLOR WAS BACK